Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
52 /100
HIGH RISK
Score updated Oct 13, 2026

LSTA — Lisata Therapeutics, Inc. Dilution Risk Tracker

Track LSTA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track LSTA — Get alerts when the score changes →

As of October 13, 2026, Lisata Therapeutics, Inc. (LSTA) has a DilutionWatch DilutionScore of 52/100, rated HIGH dilution risk. Lisata Therapeutics, Inc. has a market capitalization of $9.46M, 9.01M shares outstanding.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
85
📊 Float Risk
27
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

⛅
Watch
Minor dilution signals detected
model est. 22%
💰 Capital Raise model 35%
• Low cash runway: 5 months remaining
🔄 Reverse Split model est. 15%
• Only 5 months cash — financial pressure
🔔 Track LSTA — Get forecast alerts →

Market Data

Market Cap$9.46M
Shares Outstanding9.01M
Float7.19M
Cash$10.44M
DebtN/A
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore52/100DilutionWatch score record
Shares Outstanding9.01MVerified float table or market cache
Public Float7.19MVerified float table or market cache
Market Cap$9.46MMarket data cache
Cash Runway5.3 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 6.

Recent SEC source mix: 4 5, XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

13.4% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track LSTA for full holder detail →

Short Interest

Short Interest39.4K
Days to Cover1.0
% of Float0.6%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2012-08-15
4 INSIDER TRANSACTION 2026-01-13
4 INSIDER TRANSACTION 2026-01-13
4 INSIDER TRANSACTION 2026-01-13
4 INSIDER TRANSACTION 2026-01-13
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual LSTA Dilution Snapshot

Lisata Therapeutics, Inc. (LSTA) has a DilutionScore of 52/100, rated High dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

LSTA's DilutionScore is currently 52/100 (High risk), with 1 score change tracked over 89 days. The score improved from 46/100 (Medium risk).

Period Score Risk Level Duration
Aug 22 – Oct 13, 202652/100HIGH53 days
Jul 16 – Aug 21, 202646/100MEDIUM36 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

LSTA shares outstanding have increased 0.8% from 9.03M (Mar 2026) to 9.11M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 14, 20269.11M7.19M▲ 0.82%
May 03, 20269.11M7.13M▼ 2.00%
Mar 17, 20269.03M7.28M▲ 0.58%
Mar 15, 20269.03M7.23M▲ 2.40%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track LSTA Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment LSTA files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking LSTA — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for LSTA
LSTA FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.